| Chronic Lymphocytic Leukemia |
1 |
1 |
| Surgery |
0 |
0.9 |
| Cerebrovascular Accident |
0 |
0.66 |
| Cardiac Surgery |
0 |
0.64 |
| Biologic Therapy |
0 |
0.59 |
| Targeted Cancer Therapy |
0 |
0.37 |
| Blood Transfusion |
0 |
0.32 |
| Blood |
0 |
0.28 |
| Patient Safety |
0 |
0.25 |
| Platelet Transfusion |
0 |
0.22 |
| Platelet Count |
0 |
0.17 |
| Postoperative |
0 |
0.17 |
| Transfusion |
0 |
0.17 |
| Tyrosine Kinase Inhibitor |
0 |
0.16 |
| Hemorrhage |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| Leukemia |
0 |
0.11 |
| Percutaneous Coronary Intervention |
0 |
0.11 |
| Tyrosine Kinase |
0 |
0.11 |
| Adverse Effects |
0 |
0.06 |
| Anemia |
0 |
0.06 |
| Angiography |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Cardiovascular Imaging |
0 |
0.06 |
| Electrocardiogram (ECG) |
0 |
0.06 |
| Electrophysiology |
0 |
0.06 |
| Hematology |
0 |
0.06 |
| Hip Replacement |
0 |
0.7 |
| Lymphoma |
0 |
0.06 |
| Monoclonal Antibody |
0 |
0.06 |
| Multidisciplinary Team |
0 |
0.06 |
| Neutropenia |
0 |
0.06 |
| Perioperative Care |
0 |
0.06 |
| Quality of Life |
0 |
0.8 |
| Stress |
0 |
0.06 |
| Thrombocytopenia |
0 |
0.06 |
| Weight Loss |
0 |
0.06 |
| Weight Management |
0 |
0.06 |